Dihashita Tablet 50/850 mg
Sitagliptin Phosphate Hydrate · Metformin Hydrochloride
Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.
MFDS item code 201506651 · Approved 2015.09.21
This product's status changed to Approval withdrawn on 2023.08.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This medicine helps improve blood sugar control in patients with type 2 diabetes. It can be used as a monotherapy when blood sugar control is difficult in combination with diet and exercise. If sufficient effect is not seen with monotherapy of metformin or sitagliptin, or if both medications are being used, this medicine (sitagliptin/metformin combination) can be used to substitute or add to enhance therapeutic effectiveness. Furthermore, if blood sugar control is insufficient when used in combination with sulfonylureas, thiazolidinediones, or insulin, this medication is administered to supplement blood sugar control. It is used in various therapeutic stages to improve blood sugar control.
This medicine is generally taken twice daily with food, gradually increasing the dosage to reduce gastrointestinal side effects caused by metformin. 1. Patients who are not currently being treated with metformin: This medication 50/500 mg is taken 1 tablet twice a day, and it can be increased to 50/1000 mg taken 1 tablet twice a day. 2. Patients receiving treatment with metformin:
This medicine is used for the treatment of diabetes and contains two active ingredients: sitagliptin and metformin. First, sitagliptin can rarely cause serious allergic reactions, so if symptoms such as rash, difficulty breathing, or swelling of the face or lips occur, use should be stopped immediately. It can also cause acute pancreatitis, so if symptoms like abdominal pain, nausea, or vomiting arise, consult a doctor promptly. Metformin can cause rare but life-threatening metabolic disorders called lactic acidosis, so it should not be used in patients with poor kidney function or liver dysfunction. This medicine should not be administered to patients with reduced kidney function, severe infections, heart failure, or acute myocardial infarction, and especially should be temporarily discontinued before and after tests using iodinated contrast media. While taking this medication, there is a risk of hypoglycemia, so it is essential to maintain regular meal times and avoid sudden exercise or alcohol consumption. Additionally, vitamin B12 deficiency may occur, making it important to regularly perform blood tests to monitor the condition. It is advisable not to use this medicine in pregnant or potentially pregnant women, breastfeeding mothers, and children and adolescents under 18 years of age. Elderly patients may have reduced kidney function, so dosage adjustments and regular kidney function tests are necessary. Possible adverse effects during use include diarrhea, nausea, vomiting, headache, upper respiratory infection, and if severe joint pain or skin reactions occur, inform a doctor immediately. In case of overdose, general treatment can be applied and, if necessary, the drug can be removed through blood dialysis. Finally, this medicine may interact with other drugs, so it is important to consult healthcare professionals about all medications being taken, especially when used with drugs affecting kidney function.
Hives, severe swelling (angioedema), anaphylaxis, exfoliative skin diseases (including Stevens-Johnson syndrome), severe allergic reactions, acute pancreatitis (including fatal/non-fatal hemorrhagic or necrotizing pancreatitis), acute renal failure, worsening renal function, difficulty breathing, acute or chronic metabolic acidosis (including lactic acidosis) and coma, severe hypoglycemia with disabling symptoms, liver dysfunction (elevated liver enzyme levels, symptoms related to jaundice are explicitly mentioned)
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent air from entering, at a temperature between 1 to 30 degrees Celsius. This helps to maintain its effectiveness and prevent deterioration.
Pink oval film-coated tablet
56 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate · Metformin Hydrochloride
Prescription medication · Combination
Aprogen Pharmaceuticals, Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkun Dang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
Jong Kun Dang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
JongKeunDang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Sitagliptin Phosphate 62.04mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.